eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes. Scientific Reports, 2019; 9 (1) DOI: 10.1038/s41598-018-38341-5; ...

Scientists from the NIH have developed a mouse model of type 2 diabetes. Type 2 diabetes is a common endocrinological disorder that affects between six and ten percent of the Western world. As ...

A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a ...

The nonobese diabetic mouse as a model of autoimmune diabetes - immune dysregulation gets the NOD. Immunity 7 , 727–738 (1997). Article CAS Google Scholar ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

At right, there are far fewer insulin-producing cells in an islet from a mouse carrying the mutation that causes neonatal diabetes. Credit: Molecular Metabolism (2025). DOI: 10.1016/j.molmet.2025. ...

These drugs, which mimic the gut hormone glucagon-like peptide-1 (GLP-1), can help treat those with type 2 diabetes by stimulating the production of insulin and improving the function of beta cells.

Tests in mouse models of diabetes suggests that an experimental drug could help 'regrow' insulin-producing beta cells, thereby reversing the disease. Medical News Today Health Conditions ...

While not as dramatic as beta-cell TXNIP knockouts, the alpha-cell knockout improved diabetes-associated hyperglycemia and hyperglucagonemia in a mouse model of streptozotocin-induced diabetes.

People with diabetes are more prone to developing Staphylococcus aureus, ... The researchers brought their labs together to conduct a study with antibiotics in a diabetic mouse model of the Staph ...

Diabetes affects the body’s ability to control glucose, often causing excess glucose to build up in the bloodstream. Staph feeds off these high sugar levels, allowing it to reproduce more rapidly.